期刊文献+

高敏C反应蛋白对急性ST段抬高型心肌梗死患者近期预后的预测价值 被引量:1

The Predictive Value of High Sensitivity C Reactive Protein for Short Term Prognosis of Patients with Acute ST Segment Elevation Myocardial Infarction
暂未订购
导出
摘要 目的观察高敏C反应蛋白(hsCRP)对急性ST段抬高型心肌梗死患者近期预后的预测价值。方法选取60例急性ST段抬高型心肌梗死患者作为研究对象,测定患者hsCRP水平,观察患者的心功能指标、心肌损伤标志物,绘制ROC曲线图,计算其敏感性、特异性、阳/阴性预测值和准确性。记录心血管事件的发生率,按照有无心血管事件分为事件组和非事件组。结果事件组中患者的年龄、hsCRP以及糖尿病水平较非事件组高,但男性、LVEF、吸烟则较非事件组低(P<0.05);LVEF、hsCRP存在预测价值,ROC曲线结果表明其最佳阀值为12 mg/L,预测心血管事件的特异性为85.44%、敏感性为47.37%、阴性预测值为74.38%、阳性预测值为56.37%、准确性为72.47%。单因素分析结果提示,吸烟、年龄、糖尿病、hsCRP、LVEF与预后有相关。结论 hsCRP能够有效预测急性ST段抬高型心肌梗死患者近期情况,尤其是心绞痛、心律失常、心源性休克的发生。 Objective To observe the predictive value of high sensitivity C reactive protein (hsCRP) for short term prognosis of patients with acute ST segment elevation myocardial infarction. Methods 60 patients with acute ST segment elevation myocardial infarction were selected as research subject. The hsCRP levels were detected, and the heart functional indexes and myocardial injury markers were observed and recorded. The ROC curve chart were drawn, and its sensitivity, specificity, positive and negative predictive value and accuracy were calculated. The incidences of cardiovascular events were recorded. All cases were divided into event group and non event group according to the occurrence of cardiovascular events. Results The age, hsCRP and diabetes levels of patients in the event group were significantly higher than those in the non event group, but the men, LVEF, smoking were lower than those in the non event group (all P〈0.05). The LVEF, hsCRP had predictive value, and the ROC curve results showed that the optimal threshold was 12 mg/L, the specificity to forecast cardiovascular events was 85.44%, the sensitivity was 47.37%, the negative predictive value was 74.38%, the positive predictive value was 56.37%, and accuracy was 72.47%. Univariate analysis showed that smoking, age, diabetes, LVEF, and hsCRP level were associated with the prognosis. Conclusions The high sensitivity C reactive protein can effectively predict the recent situation of patients with acute ST segment elevation myocardial infarction, especially the incidences of angina pectoris, arrhythmia and cardiac shock.
作者 卢森荣 LU Senrong(Department of Emergency, Shantou Central Hospital / Affiliated Shantou Hospital of Sun Yet-Sen University, Shantou 515031, China)
出处 《临床医学工程》 2016年第12期1643-1644,共2页 Clinical Medicine & Engineering
关键词 高敏C反应蛋白 ST段抬高 心肌梗死 预后 High sensitivity C reactive protein ST segment elevation Myocardial infarction Prognosis
  • 相关文献

参考文献7

二级参考文献56

  • 1杨平,杭永伦,温先勇,蔡美珠,刘应才.冠心病患者炎症标志物检测的临床意义[J].医学理论与实践,2007,20(1):9-10. 被引量:2
  • 2Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation ,2002,105 : 1135-1143.
  • 3Mendall MA, Strachan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J,2000,21:1584-1590.
  • 4Schnabel R, Rupprecht HJ, Lackner KJ, et al. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J,2005,26:241-249.
  • 5Tommasi S, Carluccio E, Bentivoglio M, et al. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol, 1999,83 : 1595-1599.
  • 6Mega JL, Morrow DA, De Lemos JA, et al. B-type natfiuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction : an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol, 2004,44:335-339.
  • 7Akkus MN, Polar G, Yurtdas M, et al. Admission levels of C-reac- tive protein and plasminogen activator inhibitor-1 in patients with acute myocardial infarction with and without cardiogenic shock or heart failure on admission. Int Heart J,2009,50:33-45.
  • 8Berton G, Cordiano R, Palmieri R, et al. C-reactive protein in acute myocardial infarction: association with heart failure. Am Heart J, 2003,145 : 1094-1101.
  • 9Scifica BM, Morrow DA, Cannon CP, et al. Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. Clinical Chemistry,2007,53 : 1800-1807.
  • 10Katayama T, Iwasaki Y, Yamamoto T, et al. "Smoker' s paradox" in patients with acute myocardial infarction receiving primary coronary intervention . Cardio1,2006,48 : 193-200.

共引文献100

同被引文献7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部